Journey Medical Corporation Common Stock

DERMNASDAQ • USD
6.67 USD
↘ 0.06 (0.82%)🟢LIVE (AS OF 03:41 PM EDT)
🟢Market: OPEN

Journey Medical Corporation Common Stock (DERM) is currently trading at $6.67. Both sides of the analysis point lower: technicals flash "Strong Sell" and fundamentals confirm with a "Sell" reading. Notable factors include a concerning Altman Z-Score in the distress zone, negative Return on Equity and a bullish Golden Cross on the moving averages. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.

Technical & fundamental data as of Oct 1, 2026.

Open?$6.83
High?$6.87
Low?$6.41
Prev. Close?$6.72
Volume?107.3K
Avg. Volume?170.1K
VWAP?$6.63
Rel. Volume?0.63x
Bid / Ask
Bid?$6.55 × 100
Ask?$6.70 × 100
Spread?$0.15
Midpoint?$6.63
Valuation & Ratios
Market Cap?189.7M
Shares Out?22.2M
Float?12.0M
Float %?55.9%
P/E Ratio?N/A
P/B Ratio?5.91
EPS?-$0.22
Dividend?0.00%
Ex-Dividend?N/A
RelatedFBIO
News
Profile
Journey Medical Corp is a commercial-stage pharmaceutical company that focuses on the selling and marketing of U.S. Food and Drug Administration (FDA) approved prescription pharmaceutical products for the treatment of dermatological conditions. Its current product portfolio includes FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. The company views its operations and manages its business in one segment, which reflects products for the treatment of dermatological conditions. The dermatological segment derives revenues from the sale of branded and authorized general prescription products that treat certain dermatological conditions.
Employees
58
Market Cap
189.7M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2021-11-12
Address
9237 E VIA DE VENTURA BLVD., SUITE 105
SCOTTSDALE, AZ 85258
Phone: 480-434-6670
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▲ Bullish(+1/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
23
Z-Score?
13
Momentum?
65
Short Sent.?
39
Piotroski F-Score?3/9Weak
Altman Z-Score?1.15Distress
Confidence?57%Low
Full Fundamental Analysis →
Short InterestSqueeze Risk
Short % of Float?24.31%Squeeze Risk
Short Interest?2.9M
Days to Cover?22.5
Free Float12.0M
Avg Daily Volume130.0K
Settlement Date2026-09-15
Financial Health
Current Ratio?1.59Adequate
Quick Ratio?1.41Adequate
Cash Ratio?0.56Adequate
Debt/Equity?0.81Moderate
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
92/100
P/E?
N/A▾
P/B?
Peers
50
S&P
31
5.91FAIR▾
P/S?
Peers
50
S&P
53
2.84CHEAP▾
P/FCF?
N/A▾
EV/EBITDA?
Peers
100
S&P
97
-2,566.4CHEAP▾
EV/Sales?
S&P
63
2.84CHEAP▾
Returns & Efficiency
ROE?
Peers
50
S&P
8
-19.0%WEAK▾
ROA?
Peers
50
S&P
3
-6.2%WEAK▾
Cash Flow & Enterprise
FCF?$-7492000
Enterprise Value?$189.9M
Fundamentals ratios updated end of day